Description

Neuralgin (gabapentin) capsules 100 mg. №100

Ingredients

Active ingredient: Gabapentin 100 mg.
Other ingredients: Lactose monohydrate, maize starch, talc, and magnesium stearate.

Dosage

Adults: The usual dose is 300 mg three times a day. Your doctor may increase the dose as needed.
Children: Dosage is based on weight. Follow your doctor’s instructions.

Indications

Neuralgin (gabapentin) capsules are indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and as adjunctive therapy in the treatment of partial seizures.

Contraindications

Do not use Neuralgin (gabapentin) capsules if you are allergic to gabapentin or any other ingredients in the product. Consult your doctor before use if you have kidney problems.

Directions

Swallow the capsules whole with a full glass of water. Do not crush or chew the capsules. Take as directed by your healthcare provider.

Scientific Evidence

Gabapentin, the active ingredient in Neuralgin, has been extensively studied for its efficacy in managing neuropathic pain and seizures. Research published in the *Journal of Pain Research* demonstrated the effectiveness of gabapentin in reducing neuropathic pain intensity and improving quality of life in patients with diabetic neuropathy.

Additional Information

It is important to follow your doctor’s instructions carefully when taking Neuralgin (gabapentin) capsules. Do not suddenly stop taking the medication without consulting your healthcare provider as it may lead to withdrawal symptoms. Inform your doctor about all medications you are currently taking to avoid any potential drug interactions.

Pharmacological Effects: Gabapentin exerts its effects by modulating calcium channels in the nervous system, which reduces the release of excitatory neurotransmitters. This action helps in controlling seizures and neuropathic pain.

Clinical Trials: Clinical trials have shown that gabapentin is effective in reducing pain intensity and improving sleep quality in patients with neuropathic pain conditions. A study published in the *European Journal of Pain* found that gabapentin significantly reduced pain scores in patients with postherpetic neuralgia compared to placebo.